Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $299,075 | 111 | 89.4% |
| Travel and Lodging | $31,690 | 31 | 9.5% |
| Food and Beverage | $3,624 | 70 | 1.1% |
| Entertainment | $189.18 | 1 | 0.1% |
| Unspecified | $55.67 | 1 | 0.0% |
| Education | $2.00 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $263,341 | 158 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $40,210 | 21 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $23,561 | 15 | $0 (2020) |
| Actelion Clinical Research, Inc. | $5,600 | 7 | $0 (2017) |
| Regeneron Pharmaceuticals, Inc. | $605.00 | 1 | $0 (2022) |
| Abbott Laboratories | $398.90 | 4 | $0 (2019) |
| Resmed Corp | $388.93 | 3 | $0 (2018) |
| Impulse Dynamics (USA) Inc. | $180.54 | 1 | $0 (2023) |
| CVRx, Inc. | $120.00 | 1 | $0 (2023) |
| ABIOMED | $65.06 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,431 | 21 | Merck Sharp & Dohme LLC ($19,325) |
| 2023 | $10,935 | 11 | Merck Sharp & Dohme LLC ($10,635) |
| 2022 | $4,078 | 7 | Merck Sharp & Dohme LLC ($3,473) |
| 2021 | $7,475 | 6 | Merck Sharp & Dohme Corporation ($7,475) |
| 2020 | $26,145 | 19 | Merck Sharp & Dohme Corporation ($18,100) |
| 2019 | $92,431 | 44 | Merck Sharp & Dohme Corporation ($61,198) |
| 2018 | $89,736 | 43 | Merck Sharp & Dohme Corporation ($66,741) |
| 2017 | $84,403 | 64 | Merck Sharp & Dohme Corporation ($76,394) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $315.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $254.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $219.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $125.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $51.28 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/07/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $54.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $120.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $9,677.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $357.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $76.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $357.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $128.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $409.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $90.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Consulting Fee | Cash or cash equivalent | $1,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/10/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Travel and Lodging | In-kind items and services | $464.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/10/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $73.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/10/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: CARDIOVASCULAR | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Bona-fide Clinical Trial | Resmed Corp | $55.67 | 1 |
About Christopher O'connor
Christopher O'connor is a Cardiovascular Disease healthcare provider based in Falls Church, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659455541.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher O'connor has received a total of $334,635 in payments from pharmaceutical and medical device companies, with $19,431 received in 2024. These payments were reported across 215 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($299,075).
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Falls Church, VA
- Active Since 10/25/2006
- Last Updated 02/23/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1659455541
Products in Payments
- MK-1242 (Drug) $201,820
- VERQUVO (Drug) $59,009
- Non-Covered (Drug) $15,250
- Non-Covered $8,311
- ApneaLink (Device) $189.18
- OPTIMIZER (Device) $180.54
- Xience V coronary stent system (Device) $150.00
- AirFit (Device) $144.08
- Absolute Pro vascular stent system (Device) $141.81
- Barostim Neo System (Device) $120.00
- Impella (Device) $65.06
- Resolute (Device) $59.40
- AirCurve (Device) $55.67
- No Associated Product (Device) $54.28
- WAINUA (Drug) $54.09
- CardioMEMS HF System (Device) $52.81
- Repatha (Biological) $51.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Falls Church
Noah Jones, M.d, M.D
Cardiovascular Disease — Payments: $575,518
Wayne Batchelor, M.d, M.D
Cardiovascular Disease — Payments: $209,669
Dr. Alexander Truesdell, M.d, M.D
Cardiovascular Disease — Payments: $208,947
Dr. Tariq Haddad, M.d, M.D
Cardiovascular Disease — Payments: $64,685
Dr. Behnam Tehrani, M.d, M.D
Cardiovascular Disease — Payments: $57,629
Nadim Geloo, M.d, M.D
Cardiovascular Disease — Payments: $43,053